Search results
Results From The WOW.Com Content Network
Diethylaminosulfur trifluoride (DAST) is the organosulfur compound with the formula Et 2 NSF 3. This liquid is a fluorinating reagent used for the synthesis of organofluorine compounds . [ 1 ] The compound is colourless; older samples assume an orange colour.
The synthesis of aspirin is classified as an esterification reaction. Salicylic acid is treated with acetic anhydride, an acid derivative, causing a chemical reaction that turns salicylic acid's hydroxyl group into an ester group (R-OH → R-OCOCH 3). This process yields aspirin and acetic acid, which is considered a byproduct of this reaction.
In short, aspirin buffers and transports the protons, acting as a competitor to ATP synthase. When high doses of aspirin are given, aspirin may actually cause hyperthermia due to the heat released from the electron transport chain, as opposed to the antipyretic action of aspirin seen with lower doses.
The U.S. ASA patent expired in 1917, but Sterling owned the aspirin trademark, which was the only commonly used term for the drug. In 1920, United Drug Company challenged the Aspirin trademark, which became officially generic for public sale in the U.S. (although it remained trademarked when sold to wholesalers and pharmacists). With demand ...
The mechanism of fluorination by DAST parallels that of sulfur tetrafluoride. Attack of the hydroxyl group of the substrate on sulfur and elimination of hydrogen fluoride lead to an alkoxyaminosulfur difluoride intermediate. Nucleophilic attack by fluoride, either by an S N 1 [5] or S N 2 [6] pathway, leads to the product. Although clean ...
English: A diagram showing the chemical synthesis of aspirin. العربية: رسم توضيحي يوضح التركيب الكيميائي للأسبرين. Español: Un diagrama que muestra la síntesis química de la aspirina.
"Aspirin only has a benefit if someone is at increased risk for heart disease. They shouldn't be starting just because they have reached a certain age," Dr. Chien-Wen Tseng, a member of the 16 ...
An alternative credit for developing aspirin has also been offered. In 1949, ex-Bayer employee Arthur Eichengrün published a paper in Pharmazie, in which he claimed to have planned and directed Hoffman's synthesis of aspirin along with the synthesis of several related compounds. He also claimed to be responsible for aspirin's initial ...